Role of Prophylactic Tranexamic Acid in Reducing Blood Loss During Elective Caesarean Section for Placenta Praevia Major
Condition(s):Hemorrhage From Placenta Previa, With DeliveryLast Updated:January 12, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Hemorrhage From Placenta Previa, With DeliveryLast Updated:January 12, 2021Unknown status
Condition(s):Peptic Ulcer HemorrhageLast Updated:February 1, 2023Recruiting
Condition(s):Blood LossLast Updated:March 4, 2016Completed
Condition(s):Acute or Programmed Hip Replacement (Gamma Nail, Total Prosthesis or Throuhg DHS) / Knee SurgeryLast Updated:February 11, 2020Terminated
Condition(s):Postpartum HemorrhageLast Updated:August 22, 2022Completed
Condition(s):MyomaLast Updated:May 2, 2022Recruiting
Condition(s):Coronary Occlusion/Thrombosis; Peptic Ulcer HemorrhageLast Updated:November 11, 2015Completed
Condition(s):GastroIntestinal Bleeding; Anticoagulant-induced BleedingLast Updated:March 22, 2022Not yet recruiting
Condition(s):Bleeding; AnemiaLast Updated:April 10, 2015Completed
Condition(s):Pulmonary Hemorrhage; MAPCA – Major Aortopulmonary Collateral ArteryLast Updated:August 3, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.